Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Consiglia Trotta

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Therapeutic Advances in Musculoskeletal Disease|January 11, 2024
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucoseMaria Consiglia Trotta, Annalisa Itro, Caterina Claudia Lepre, et al.
World Journal of Gastroenterology|April 5, 2024
Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity?Antonietta Gerarda Gravina, Iacopo Panarese, Maria Consiglia Trotta, et al.
Medicina (Kaunas, Lithuania)|May 4, 2026
Current Perspective on Orthobiology Applications for the Treatment of Intervertebral Disc Degeneration (IDD)-A Narrative ReviewGianluca Conza, Maria Consiglia Trotta, Chiara Mastronardi, et al.
Frontiers in Pharmacology|August 28, 2020
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth FactorsFrancesca Lazzara, Maria Consiglia Trotta, Chiara Bianca Maria Platania, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|January 10, 2022
Comparison of Timing to Develop Anti-Drug Antibodies to Infliximab and Adalimumab Between Adult and Pediatric Age Groups, Males and FemalesMaria Consiglia Trotta, Roberto Alfano, Giovanna Cuomo, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
Melanocortin receptor agonists MCR<sub>1-5</sub> protect photoreceptors from high-glucose damage and restore antioxidant enzymes in primary retinal cell cultureRosa Maisto, Carlo Gesualdo, Maria Consiglia Trotta, et al.
Plos One|January 19, 2019
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasomeMaria Consiglia Trotta, Rosa Maisto, Francesca Guida, et al.
International Journal of Molecular Sciences|July 12, 2025
Inflammaging-Driven Osteoporosis: Is a Galectin-Targeted Approach Needed?Marina Russo, Caterina Claudia Lepre, Annalisa Itro, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 23, 2023
Infliximab therapy decreases the expression of serum and faecal miR-126 and miR-20a in paediatric Crohn's disease: A pilot studyMarianna Casertano, Maria Consiglia Trotta, Sabrina Cenni, et al.
Biochemical Pharmacology|February 19, 2021
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets?Maria Consiglia Trotta, Carlo Gesualdo, Chiara Bianca Maria Platania, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Therapeutic Advances in Musculoskeletal Disease|January 11, 2024
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucoseMaria Consiglia Trotta, Annalisa Itro, Caterina Claudia Lepre, et al.
World Journal of Gastroenterology|April 5, 2024
Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity?Antonietta Gerarda Gravina, Iacopo Panarese, Maria Consiglia Trotta, et al.
Medicina (Kaunas, Lithuania)|May 4, 2026
Current Perspective on Orthobiology Applications for the Treatment of Intervertebral Disc Degeneration (IDD)-A Narrative ReviewGianluca Conza, Maria Consiglia Trotta, Chiara Mastronardi, et al.
Frontiers in Pharmacology|August 28, 2020
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth FactorsFrancesca Lazzara, Maria Consiglia Trotta, Chiara Bianca Maria Platania, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|January 10, 2022
Comparison of Timing to Develop Anti-Drug Antibodies to Infliximab and Adalimumab Between Adult and Pediatric Age Groups, Males and FemalesMaria Consiglia Trotta, Roberto Alfano, Giovanna Cuomo, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
Melanocortin receptor agonists MCR<sub>1-5</sub> protect photoreceptors from high-glucose damage and restore antioxidant enzymes in primary retinal cell cultureRosa Maisto, Carlo Gesualdo, Maria Consiglia Trotta, et al.
Plos One|January 19, 2019
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasomeMaria Consiglia Trotta, Rosa Maisto, Francesca Guida, et al.
International Journal of Molecular Sciences|July 12, 2025
Inflammaging-Driven Osteoporosis: Is a Galectin-Targeted Approach Needed?Marina Russo, Caterina Claudia Lepre, Annalisa Itro, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 23, 2023
Infliximab therapy decreases the expression of serum and faecal miR-126 and miR-20a in paediatric Crohn's disease: A pilot studyMarianna Casertano, Maria Consiglia Trotta, Sabrina Cenni, et al.
Biochemical Pharmacology|February 19, 2021
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets?Maria Consiglia Trotta, Carlo Gesualdo, Chiara Bianca Maria Platania, et al.
Pageof 9